Photothermal therapy

$2.2 Billion Worldwide Photodynamic Therapy Industry to 2031 - Rise in Healthcare Expenditure Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 4, 2023
Health, General Health, Benchmark, Skin, Cancer, PDT, Sun Pharma, Coronavirus, Drug development, Research, COVID-19, Growth, Patient, Bausch Health, Infection, Cosmetics, Insurance, Degenerative disease, Create, Conditional sentence, Dermatology, Ageing, Photothermal therapy, Prevalence, COVID, Intelligence, Animal, Marketing, Pharmaceutical industry

Factors that could hinder the growth of the photodynamic therapy market in the future include COVID-19, photosensitivity reactions and lack of healthcare infrastructure.

Key Points: 
  • Factors that could hinder the growth of the photodynamic therapy market in the future include COVID-19, photosensitivity reactions and lack of healthcare infrastructure.
  • North America was the largest region in the photodynamic therapy market, accounting for 37.2% of the total in 2021.
  • The global photodynamic therapy market is fairly concentrated, and the market has limited number of large players.
  • The photodynamic therapy market size will gain the most in the USA at $149.2 million.

2022 SPIE-Franz Hillenkamp Postdoctoral Fellowship Awarded to Ivan Kosik

Retrieved on: 
Thursday, December 2, 2021
Oncology, Medical Devices, Health, Surgery, Radiology, Biotechnology, Calibration, University, Technology, Book, Beckman Laser Institute, Partnership, Health, Photothermal therapy, Cancer, Doctor of Philosophy, Boston University, PTT, Google Images, Massachusetts General Hospital, Society, Collateral damage, Research, Risk, MRI, Hospital, Public policy, Engineering, Multimedia, Franz Hillenkamp, Massachusetts, Medical imaging

SPIE, the international society for optics and photonics , has announced Ivan Kosik, who received his PhD in 2018 from the University of Western Ontario, as the winner of the 2022 SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics .

Key Points: 
  • SPIE, the international society for optics and photonics , has announced Ivan Kosik, who received his PhD in 2018 from the University of Western Ontario, as the winner of the 2022 SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics .
  • View the full release here: https://www.businesswire.com/news/home/20211202005814/en/
    Ivan Kosik using a diffuse optical tomography system to map out the laser fluence intensity in a 3D imaging volume.
  • This type of calibration can significantly increase the accuracy of photoacoustic tomography, permitting quantitative imaging and precision photothermal cancer therapy guidance.
  • "Being awarded the 2022 SPIE Hillenkamp Fellowship represents a high point in my career to date, says Kosik.

An innovative imaging technique for dynamic optical nanothermometry

Retrieved on: 
Tuesday, November 9, 2021
Canadian Cancer Society, 2D, MONTRAL, Cancer, Engineering, Canada Foundation for Innovation, Photothermal therapy, Student, Varennes-en-Argonne, Melanoma, Vetronics, Doctor of Philosophy, Technology, Luminescence, Research, Skin, Fonds, Nature Communications, American Cancer Society, New, Environment, Metabolism, Innovation, INRS, Temperature, Diagnosis, Natural science, Nanoparticle, Institute, Premyer-Ministr, Interdisciplinarity, Medical imaging

This technology, known as single-shot photoluminescence lifetime imaging thermometry (SPLIT), is based on the luminescence of nanoparticles doped with rare earth ions.

Key Points: 
  • This technology, known as single-shot photoluminescence lifetime imaging thermometry (SPLIT), is based on the luminescence of nanoparticles doped with rare earth ions.
  • Instead of imaging the luminescence point by point, which is time consuming, SPLIT uses a novel ultrahigh-speed camera to track how quickly the luminescence decays of these nanoparticles in every spatial point.
  • "Our camera is different from a common one, where each click gives one image: our camera works by capturing all the images of a dynamic event into one snapshot.
  • This allows a more accurate temperature sensing with both an advanced and economical solution," adds Professor Liang, an expert in ultra-fast imaging.

PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever

Retrieved on: 
Tuesday, September 14, 2021
Nanorod, ACS Nano, Arthroscopy, Yang Mo, American Chemical Society, Quality of life, Mouse, Associate, NGF, Antibody, Hong Kong Polytechnic University, Nature Reviews Rheumatology, Physical examination, World Health Organization, Patient, Research, MRI, Thermal conductivity, Osteoarthritis, Rheumatology, Nervous system, Gold, Molybdenum, Joint, Therapy, Biomedical engineering, Nerve growth factor, World, Photothermal therapy, Wallace H. Coulter Department of Biomedical Engineering, Nanotechnology, Nanoparticle, Photoacoustic imaging, Obesity, Biomedicine, Department, Optical flow, Heat, Pain, ACS, Population, Prevalence, Medical imaging, Vaccine, Medical device, Dentistry

The novel targeted osteoarthritis pain theranostics, which offer both diagnostics and therapeutics, are made of gold nanorods coated with a two-dimensional nanomaterial, molybdenum disulfide.

Key Points: 
  • The novel targeted osteoarthritis pain theranostics, which offer both diagnostics and therapeutics, are made of gold nanorods coated with a two-dimensional nanomaterial, molybdenum disulfide.
  • The antibody-fused nanorods enable both active and passive targeting on peripheral osteoarthritis pain generation.
  • "It is the first time the concept of targeted photothermal therapy for osteoarthritis pain via nanotechnology is being introduced," said Professor Yang.
  • In their experiment with the mouse models of osteoarthritis, the nanorods with laser stimulation reduced signs of pain for three to four days.

PolyU develops groundbreaking and highly effective targeted osteoarthritis pain reliever

Retrieved on: 
Tuesday, September 14, 2021
Nanorod, ACS Nano, Arthroscopy, Yang Mo, American Chemical Society, Quality of life, Mouse, Associate, NGF, Antibody, Hong Kong Polytechnic University, Nature Reviews Rheumatology, Physical examination, World Health Organization, Patient, Research, MRI, Thermal conductivity, Osteoarthritis, Rheumatology, Nervous system, Gold, Molybdenum, Joint, Therapy, Biomedical engineering, Nerve growth factor, World, Photothermal therapy, Wallace H. Coulter Department of Biomedical Engineering, Nanotechnology, Nanoparticle, Photoacoustic imaging, Obesity, Biomedicine, Department, Optical flow, Heat, Pain, ACS, Population, Prevalence, Medical imaging, Vaccine, Medical device, Dentistry

The novel targeted osteoarthritis pain theranostics, which offer both diagnostics and therapeutics, are made of gold nanorods coated with a two-dimensional nanomaterial, molybdenum disulfide.

Key Points: 
  • The novel targeted osteoarthritis pain theranostics, which offer both diagnostics and therapeutics, are made of gold nanorods coated with a two-dimensional nanomaterial, molybdenum disulfide.
  • The antibody-fused nanorods enable both active and passive targeting on peripheral osteoarthritis pain generation.
  • "It is the first time the concept of targeted photothermal therapy for osteoarthritis pain via nanotechnology is being introduced," said Professor Yang.
  • In their experiment with the mouse models of osteoarthritis, the nanorods with laser stimulation reduced signs of pain for three to four days.

PolyU develops biomimetic nanosheet for cancer therapy and imaging

Retrieved on: 
Monday, May 31, 2021
Medicine, Clinical medicine, Health sciences, Medical physics, Cancer treatments, Antineoplastic drugs, Oncology, Oncothermia, Photothermal therapy, Therapy, Treatment of cancer, Radiation therapy

The newly developed biomimetic nanomaterials developed by PolyU are part of our endeavours in fighting against cancer.

Key Points: 
  • The newly developed biomimetic nanomaterials developed by PolyU are part of our endeavours in fighting against cancer.
  • By integrating two emerging cancer therapies, immunotherapy and photothermal therapy, with three imaging modalities for the first time, the novel biomimetic nanomaterials provide a practical design blueprint for the development of a new generation of cancer theranostics agents which have high targeting ability, efficacy and safety."
  • New cancer treatments emerge since conventional cancer treatments like surgical therapy, chemotherapy and radiotherapy have different limitations and side effects.
  • The biomimetic nanosheets developed by our team allow us to combine these two methods for synergistic therapy.

PolyU develops biomimetic nanosheet for cancer therapy and imaging

Retrieved on: 
Monday, May 31, 2021
Medicine, Clinical medicine, Health sciences, Medical physics, Cancer treatments, Antineoplastic drugs, Oncology, Oncothermia, Photothermal therapy, Therapy, Treatment of cancer, Radiation therapy

The newly developed biomimetic nanomaterials developed by PolyU are part of our endeavours in fighting against cancer.

Key Points: 
  • The newly developed biomimetic nanomaterials developed by PolyU are part of our endeavours in fighting against cancer.
  • By integrating two emerging cancer therapies, immunotherapy and photothermal therapy, with three imaging modalities for the first time, the novel biomimetic nanomaterials provide a practical design blueprint for the development of a new generation of cancer theranostics agents which have high targeting ability, efficacy and safety."
  • New cancer treatments emerge since conventional cancer treatments like surgical therapy, chemotherapy and radiotherapy have different limitations and side effects.
  • The biomimetic nanosheets developed by our team allow us to combine these two methods for synergistic therapy.